Optimizing CD34+ Cell Genome Editing for Efficiency and HSPC Maintenance
CRISPR-Cas9 gene editing of human hematopoietic stem and progenitor (HSPC) cells holds great promise for disease treatment by cellular therapy and other methodologies. However, the variables that can affect treatment of relevant diseases in the real world are still being elucidated. A critical part of this involves implementing an optimized gene editing and cell culture methodology. In this webinar, Dr. Marta Walasek and Ms. Danielle Nguyen Truong describe tips and tricks for effective genome editing of CD34⁺ cells, methods to evaluate genome editing efficiency, as well as optimal pre- and post- editing culture conditions to maintain HSPC function and long-term editing effects.
Publish Date:
May 30, 2022
Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
By submitting this form, you are providing your consent to STEMCELL Technologies Canada Inc. and its subsidiaries and affiliates (“STEMCELL”) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.
Related Multimedia
-
Optimized Workflows for High-Efficiency Genome Editing in Stem and Primary Cell Types
Publish Date: September 09, 2019 -
Considerations for High-Efficiency Genome Editing of Human Pluripotent Stem Cells
Publish Date: May 29, 2020 -
Gene Targeting in Hematopoietic Stem Cells for Basic and Translational Research
Publish Date: November 28, 2018
Explore Our Products
-
cGMP medium, for culture and expansion of human hematopoietic cells -
Serum-free medium for culture and expansion of hematopoietic cells -
Mobilized Human Peripheral Blood CD34+ Cells, Frozen
Primary human cells, frozen
